Avalo Therapeutics (AVTX) Stock Chart & Stock Price History → America could fall from this event (From Porter & Company) (Ad) Free AVTX Stock Alerts $10.60 -0.22 (-2.03%) (As of 05/14/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Avalo Therapeutics Stock Price Performance5 Day Performance-7.75%1 Month Performance-28.86%3 Month Performance+109.49%6 Month Performance-55.34%Year-To-Date Performance+16.48%1 Year Performance-98.20% Receive AVTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyAmerica could fall from this eventAmerica’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash.Click here to see how you can protect yourself today. AVTX Stock Chart for Tuesday, May, 14, 2024 AVTX Chart by TradingView Avalo Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/14/2024$10.82$10.60-2.03%$10.66$9.5853,056 shs$10.92 million05/13/2024$10.85$10.82-0.28%$11.20$10.6354,481 shs$11.15 million05/10/2024$11.49$10.85-5.57%$11.59$10.3557,346 shs$11.18 million05/09/2024$11.73$11.49-2.05%$12.63$11.4940,130 shs$11.84 million05/08/2024$13.25$11.73-11.47%$13.20$11.25147,947 shs$12.08 million05/07/2024$13.51$13.25-1.92%$13.76$13.1431,322 shs$13.65 million Get the Latest News and Ratings for AVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/06/2024$14.36$13.51-5.92%$14.99$13.2734,733 shs$13.92 million05/03/2024$15.39$14.36-6.69%$16.00$13.1591,686 shs$14.79 million05/02/2024$16.01$15.39-3.87%$17.42$15.3953,627 shs$15.85 million05/01/2024$17.12$16.01-6.48%$17.10$14.7063,441 shs$16.49 million04/30/2024$16.88$17.12+1.42%$17.15$16.0139,078 shs$17.63 million04/29/2024$15.94$16.88+5.90%$17.49$15.6881,778 shs$17.39 million04/26/2024$14.98$15.94+6.41%$16.23$14.6978,196 shs$16.42 million04/25/2024$14.20$14.98+5.49%$16.32$13.65160,863 shs$15.43 million04/24/2024$13.00$14.20+9.23%$14.25$12.8036,845 shs$14.63 million04/23/2024$12.21$13.00+6.47%$13.74$12.3373,223 shs$13.39 million04/22/2024$11.63$12.21+4.99%$13.37$11.4683,438 shs$12.58 million04/19/2024$12.01$11.63-3.16%$13.02$11.5068,159 shs$11.98 million04/18/2024$13.62$12.01-11.82%$13.76$12.00107,236 shs$12.37 million04/17/2024$15.94$13.62-14.55%$15.93$13.52131,479 shs$14.03 million04/16/2024$15.24$15.94+4.59%$18.79$15.94220,529 shs$16.42 million04/15/2024$14.90$15.24+2.28%$15.69$14.5491,326 shs$15.70 million04/12/2024$15.75$14.90-5.40%$16.22$14.70127,024 shs$15.35 million04/11/2024$15.06$15.75+4.58%$16.39$14.76128,830 shs$16.22 million04/10/2024$14.48$15.06+4.01%$15.62$13.79146,454 shs$15.51 million04/09/2024$14.19$14.48+2.04%$14.90$11.10354,786 shs$14.91 million04/08/2024$16.40$14.19-13.48%$17.20$14.16262,380 shs$14.67 million04/05/2024$16.30$16.40+0.61%$18.30$16.01279,181 shs$1.48 million04/04/2024$16.31$16.30-0.06%$20.85$16.30616,829 shs$1.39 million04/03/2024$15.16$16.31+7.59%$19.30$14.25448,728 shs$1.47 million04/02/2024$17.90$15.16-15.31%$17.33$14.50569,278 shs$1.36 million04/01/2024$21.75$17.90-17.70%$22.47$16.051.98 million shs$1.61 million03/29/2024$21.75$21.75$34.46$16.6531.53 million shs$1.85 million03/28/2024$4.75$21.75+357.89%$34.46$16.6531.83 million shs$1.96 million03/27/2024$4.76$4.75-0.21%$4.86$4.602.94 million shs$428,000.0003/26/2024$4.74$4.76+0.42%$4.89$4.629,560 shs$428,000.0003/25/2024$4.88$4.74-2.87%$4.93$4.6311,634 shs$427,000.0003/22/2024$4.60$4.88+6.09%$4.97$4.6736,144 shs$439,000.0003/21/2024$4.47$4.60+2.91%$4.84$4.4315,531 shs$414,000.0003/20/2024$4.35$4.47+2.76%$4.58$4.3630,030 shs$402,000.00Look Who Fired the World’s Richest Man (Ad)This company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S. And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.Get the full story here.03/19/2024$4.44$4.35-2.03%$4.56$4.359,877 shs$370,000.0003/18/2024$4.37$4.44+1.60%$4.73$4.3718,411 shs$400,000.0003/15/2024$5.00$4.37-12.60%$5.07$4.3728,859 shs$393,000.0003/14/2024$5.52$5.00-9.42%$5.72$5.0033,352 shs$425,000.0003/13/2024$5.45$5.52+1.28%$5.66$5.3535,773 shs$497,000.0003/12/2024$5.61$5.45-2.85%$5.67$5.2139,300 shs$490,000.0003/11/2024$5.88$5.61-4.59%$6.18$5.5552,601 shs$505,000.0003/08/2024$5.24$5.80+10.69%$6.17$5.3289,760 shs$522,000.0003/07/2024$5.15$5.24+1.75%$5.32$4.8642,605 shs$472,000.0003/06/2024$4.50$5.15+14.44%$5.24$4.49100,158 shs$464,000.0003/05/2024$4.60$4.50-2.17%$4.62$4.469,341 shs$382,000.0003/04/2024$4.42$4.60+4.07%$4.65$4.4217,796 shs$414,000.0003/01/2024$4.41$4.51+2.27%$4.55$4.3013,263 shs$406,000.0002/29/2024$4.44$4.41-0.68%$4.60$4.2811,677 shs$397,000.0002/28/2024$4.67$4.44-4.93%$4.69$4.4418,756 shs$400,000.0002/27/2024$4.35$4.67+7.36%$4.67$4.4315,592 shs$420,000.0002/26/2024$4.28$4.35+1.64%$4.39$4.2012,031 shs$391,000.0002/23/2024$4.44$4.32-2.70%$4.47$4.287,256 shs$389,000.0002/22/2024$4.33$4.44+2.54%$4.49$4.2125,406 shs$400,000.0002/21/2024$4.20$4.33+3.22%$4.35$4.209,605 shs$390,000.0002/20/2024$4.46$4.20-5.94%$4.45$4.1815,870 shs$357,000.0002/19/2024$4.46$4.46$4.76$4.4515,300 shs$401,000.0002/16/2024$4.76$4.52-5.04%$4.79$4.4515,262 shs$407,000.0002/15/2024$5.06$4.76-5.93%$5.02$4.6840,587 shs$405,000.0002/14/2024$4.81$5.06+5.20%$5.17$4.8031,772 shs$455,000.0002/13/2024$4.84$4.81-0.62%$4.96$4.7117,145 shs$433,000.00 Related Companies: RedHill Biopharma Stock Chart Pieris Pharmaceuticals Stock Chart Monopar Therapeutics Stock Chart Kiora Pharmaceuticals Stock Chart Purple Biotech Stock Chart FSD Pharma Stock Chart Edesa Biotech Stock Chart Imunon Stock Chart Elevai Labs Stock Chart Akari Therapeutics Stock Chart Receive AVTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVTX) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsCrypto Millionaire Says: “Buy This $11 AI Coin.”InvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable ProsperityRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperThe only AI company you should be looking atBehind the MarketsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.